Several Chinese pharma firms manufacture unsafe drug capsules
The announcement follows a month-long inspection programme by SFDA who found that of the 11,561 batches of drugs tested, 5.8% were found to contain excessive levels of chromium.
US-based gene therapy biotech Seawolf Therapeutics and Sanofi have signed a multi-target research partnership and exclusive licensing deal worth up to $1.2bn to develop treatments for bleeding disorders and other undisclosed indications.